The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE - PubMed (original) (raw)

. 2016 Aug 2;87(5):473-80.

doi: 10.1212/WNL.0000000000002914. Epub 2016 Jul 1.

Andrea L C Schneider 2, Yun Zhou 2, Xueqi Chen 2, Edward Green 2, Naresh Gupta 2, David S Knopman 2, Akiva Mintz 2, Arman Rahmim 2, A Richey Sharrett 2, Lynne E Wagenknecht 2, Dean F Wong 2, Thomas H Mosley Jr 2

Affiliations

The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE

Rebecca F Gottesman et al. Neurology. 2016.

Abstract

Objective: To evaluate differences in amyloid deposition in a community-based cohort without dementia by age, sex, race, education, and APOE ε4 allele status.

Methods: Recruited from the longitudinal Atherosclerosis Risk in Communities study, 329 participants without dementia, ages 67-88 years, were imaged using florbetapir PET at 3 US community sites (Washington County, Maryland; Forsyth County, North Carolina; and Jackson, Mississippi). Standardized uptake value ratios (SUVRs) were calculated; global cortical SUVR >1.2 was evaluated as the primary outcome. Age, race, sex, education level, and number of APOE ε4 alleles were evaluated in multivariable models including vascular risk factors, brain white matter hyperintensity and total intracranial volume, and cognitive status.

Results: A total of 141 of the participants (43%) were black. In multivariable models, odds of elevated SUVR was increased in participants with increasing age (odds ratio [OR] 1.63, 95% confidence interval [CI] 1.01-2.65 per 10 years of age) and black race (OR 2.08, 95% CI 1.23-3.51) but did not differ by educational level. Each ε4 allele was associated with increased odds of elevated SUVR (OR 2.65, 95% CI 1.61-4.39).

Conclusions: In this community-based cohort without dementia, florbetapir uptake is associated with older age and APOE genotype. Black race was associated with higher SUVR, after adjusting for demographics, vascular risk factors, cognitive status, white matter hyperintensity volume, and APOE genotype, with effect sizes nearing those seen for APOE ε4. Replication of these findings is needed in other cohorts, and reasons for and consequences of these observed differences by race warrant further study.

© 2016 American Academy of Neurology.

PubMed Disclaimer

Figures

Comment in

References

    1. Jansen WJ, Ossenkoppele R, Knol DL, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 2015;313:1924–1938. - PMC - PubMed
    1. Jack CR Jr, Wiste HJ, Weigand SD, et al. Age-specific population frequencies of cerebral B-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study. Lancet Neurol 2014;13:997–1005. - PMC - PubMed
    1. Jack CR Jr, Wiste HJ, Weigand SD, et al. Age, sex, and APOE e4 effects on memory, brain structure, and B-amyloid across the adult life span. JAMA Neurol 2015;72:511–519. - PMC - PubMed
    1. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007;29:125–132. - PMC - PubMed
    1. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003;22:13–22. - PubMed

MeSH terms

Substances

Grants and funding

LinkOut - more resources